Fenofibrate Nanocrystalize
SOL #: SPE2D220R0073Solicitation
Overview
Buyer
DEPT OF DEFENSE
Defense Logistics Agency
DLA TROOP SUPPORT
PHILADELPHIA, PA, 19111, United States
Place of Performance
Place of performance not available
NAICS
Pharmaceutical Preparation Manufacturing (325412)
PSC
Drugs And Biologicals (6505)
Set Aside
No set aside specified
Original Source
Timeline
1
Posted
Aug 21, 2020
2
Last Updated
Jan 9, 2024
3
Submission Deadline
Oct 23, 2020, 7:00 PM
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Option Year 1 P00001 SPE2D2-21-D-0131 to invoke option period of April 05, 2022 through April 04, 2023.
Amendment 0001 is issued to extend the closing date until October 23, 2020 at 3:00 PM EDT.
Solicitation for Fenofibrate Nanocrystalize Tablets SPE2D2-20-R-0073.
People
Points of Contact
Phyllis DaraioPRIMARY